Inovio Pharmaceuticals Bolsters Research and Clinical Development Leadership

February 18, 2014 Inovio Pharmaceuticals, Inc. today announced it has expanded its senior management team with two appointments to help advance the company’s growing pipeline of preclinical and clinical DNA vaccines. Inovio has appointed Dr. Laurent Humeau as Vice President of R&D and Dr. Jan Marie-Albert Van Tornout as Vice President of Clinical Development. Prior to Inovio, Dr. Humeau was Senior Director …

Download: Clinical Development of SE36 Malaria Vaccine-

Earlier this year at the World Vaccine Congress Asia 2013 Congress, Toshihiro Horii, Ph.D RIMD, Osaka University delivered the presentation: Malaria: Innovating prophylactic vaccine pipeline for tropical infectious diseases -Clinical Development of SE36 Malaria Vaccine. Download this presentation to read about: Structure of SERA5 protein and SE36 recombinant molecule Correlation of anti-SE36 antibody levels with parasitemia in residents from the …